Fareast Finance & Investment Limited (DSE:FAREASTFIN)

SpringWorks Therapeutics Income Statement

Financials in millions BDT. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2020	Dec 31, 2019
Interest and Dividend Income	200.27	201.84	144.85	106.88	791.1	772.44
Total Interest Expense	859.1	829.65	670.36	716.27	833.26	1,010
Net Interest Income	-658.84	-627.81	-525.5	-609.39	-42.16	-237.18
Other Revenue	-17.67	-19.6	-8.5	-7.16	-5.76	-7.65
Revenue Before Loan Losses	-676.51	-647.41	-534	-616.55	-47.92	-244.83
Provision for Loan Losses	269.52	157.44	78.62	1,458	173.29	348.96
Revenue	-946.02	-804.84	-612.62	-2,074	-221.21	-593.78
Salaries & Employee Benefits	21.93	21.7	20.96	21.76	37.75	51.38
Cost of Services Provided	16.52	18.35	16.75	14.87	26.11	41.73
Other Operating Expenses	-6.17	-7.5	-0.82	5.63	-1.02	5.24
Total Operating Expenses	32.99	33.27	37.13	43.13	67.24	105
Operating Income	-979.01	-838.11	-649.75	-2,118	-288.45	-698.79
EBT Excluding Unusual Items	-979.01	-838.11	-975	-2,307	-302.39	-698.79
Gain (Loss) on Sale of Investments	4.24	-1.96	-0.16	0.77	14.99	-21.93
Other Unusual Items	-	-	-	0.1	-	-
Pretax Income	-974.77	-840.07	-974.69	-2,306	-284.08	-718.84
Income Tax Expense	2.33	1.66	148.54	0.69	1.38	-0.84
Net Income	-977.1	-841.73	-1,123	-2,307	-285.46	-718
Net Income to Common	-977.1	-841.73	-1,123	-2,307	-285.46	-718
Shares Outstanding (Basic)	164	164	164	164	164	164
Shares Outstanding (Diluted)	164	164	164	164	164	164
Shares Change (YoY)	0.08%	-	-	-	-	-
EPS (Basic)	-5.96	-5.13	-6.85	-14.06	-1.74	-4.38
EPS (Diluted)	-5.96	-5.13	-6.85	-14.06	-1.74	-4.38
Free Cash Flow	-228.58	-182.7	-310.39	-175.04	302.31	-195.26
Free Cash Flow Per Share	-1.39	-1.11	-1.89	-1.07	1.84	-1.19

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.